AR061484A1 - Secuencias de adn vectores proteinas y usos de hemaglutinina de gripe aviar - Google Patents
Secuencias de adn vectores proteinas y usos de hemaglutinina de gripe aviarInfo
- Publication number
- AR061484A1 AR061484A1 ARP070102645A ARP070102645A AR061484A1 AR 061484 A1 AR061484 A1 AR 061484A1 AR P070102645 A ARP070102645 A AR P070102645A AR P070102645 A ARP070102645 A AR P070102645A AR 061484 A1 AR061484 A1 AR 061484A1
- Authority
- AR
- Argentina
- Prior art keywords
- antigen
- genes
- formulation
- amino acid
- acid sequences
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 239000013598 vector Substances 0.000 title abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 229960005486 vaccine Drugs 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 206010022000 influenza Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000009261 transgenic effect Effects 0.000 abstract 2
- 108020004705 Codon Proteins 0.000 abstract 1
- 108091035707 Consensus sequence Proteins 0.000 abstract 1
- 101710082439 Hemagglutinin A Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/517—Plant cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81424106P | 2006-06-16 | 2006-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR061484A1 true AR061484A1 (es) | 2008-08-27 |
Family
ID=38834237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070102645A AR061484A1 (es) | 2006-06-16 | 2007-06-15 | Secuencias de adn vectores proteinas y usos de hemaglutinina de gripe aviar |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8163876B2 (enExample) |
| EP (1) | EP2029167A4 (enExample) |
| JP (1) | JP2009540801A (enExample) |
| KR (1) | KR20090027216A (enExample) |
| CN (1) | CN101472607A (enExample) |
| AR (1) | AR061484A1 (enExample) |
| AU (1) | AU2007261196A1 (enExample) |
| BR (1) | BRPI0713671A2 (enExample) |
| CA (1) | CA2654178A1 (enExample) |
| WO (1) | WO2007149715A2 (enExample) |
| ZA (1) | ZA200808845B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1833030B (zh) | 2003-05-22 | 2014-07-23 | 美国弗劳恩霍夫股份有限公司 | 用于表达、传递及纯化目标多肽的重组载体分子 |
| BRPI0614475B8 (pt) | 2005-08-03 | 2021-05-25 | Fraunhofer Usa Inc | polipeptídeo, anticorpo, ácido nucleico, vetores, célula hospedeira, composição e processos de produção de anticorpo |
| EP2029167A4 (en) * | 2006-06-16 | 2010-06-16 | Dow Agrosciences Llc | NEW DNA SEQUENCES, VECTORS AND PROTEINS OF BIRD FLUID HEMOGGLUTININE |
| EP2092059A4 (en) | 2006-10-24 | 2012-03-28 | Bogoch Samuel | METHOD FOR FORECASTING INFLUENZA EXCESSIONS BY CORRELATION OF AN INCREASED REPLICINE MIRROR IN WHITE SPOT AND / OR TAURA VIRUSES IN CRABES |
| JP5675348B2 (ja) | 2007-05-30 | 2015-02-25 | ボゴーク，サミュエル | 水産養殖における無脊椎動物の病原性感染に対する合成レプリキンペプチド |
| CA2692933C (en) | 2007-07-11 | 2016-10-18 | Fraunhofer Usa, Inc. | Yersinia pestis antigens, vaccine compositions, and related methods |
| EP2300493A2 (en) * | 2008-04-23 | 2011-03-30 | Samuel Bogoch | Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles |
| ES2593277T3 (es) * | 2008-07-18 | 2016-12-07 | Medicago Inc. | Nuevo epítopo de inmunización contra el virus de la influenza |
| WO2010036970A2 (en) * | 2008-09-25 | 2010-04-01 | Fraunhofer Usa, Inc. | Influenza vaccines, antigens, compositions, and methods |
| US8734803B2 (en) | 2008-09-28 | 2014-05-27 | Ibio Inc. | Humanized neuraminidase antibody and methods of use thereof |
| US9233148B2 (en) | 2009-01-09 | 2016-01-12 | Samuel Bogoch | Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza |
| CA2759325A1 (en) * | 2009-04-23 | 2010-10-28 | Samuel Bogoch | Replikin-sequences for preventing/treating influenza and determining infectivity/lethality |
| WO2011041391A1 (en) | 2009-09-29 | 2011-04-07 | Fraunhofer Usa, Inc. | Influenza hemagglutinin antibodies, compositions, and related methods |
| CN101693894B (zh) * | 2009-10-15 | 2011-07-27 | 北京大学深圳研究生院 | 禽流感病毒h5n1假病毒及其制备方法与专用dna片段 |
| AR083533A1 (es) * | 2010-10-22 | 2013-03-06 | Boehringer Ingelheim Vetmed | Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe |
| WO2013013075A2 (en) | 2011-07-20 | 2013-01-24 | Samuel Bogoch | Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
| CN116218900A (zh) * | 2011-09-30 | 2023-06-06 | 麦迪卡格公司 | 增加植物中病毒样颗粒的产率 |
| US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| RU2531235C2 (ru) | 2013-02-15 | 2014-10-20 | Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") | Поливалентная вакцина против гриппа на основе гибридного белка |
| WO2015048129A1 (en) * | 2013-09-24 | 2015-04-02 | CHOI, Duk, Kyung | Avian influenza virus polypeptides and methods of their use |
| US10513553B2 (en) | 2015-11-13 | 2019-12-24 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| CA3015347A1 (en) | 2016-02-24 | 2017-08-31 | Visterra, Inc. | Formulations of antibody molecules to influenza virus |
| GB2578163A (en) * | 2018-10-19 | 2020-04-22 | Univ Pretoria | Plant produced avian influenza antigens and their uses in diagnostic assays and devices |
| JP2022521819A (ja) | 2019-03-25 | 2022-04-12 | ビステラ， インコーポレイテッド | インフルエンザを処置および予防するための組成物および方法 |
| US20240191245A1 (en) * | 2021-03-18 | 2024-06-13 | Calyxt, Inc. | Plant cell matrices and methods thereof |
| WO2023032008A1 (ja) * | 2021-08-30 | 2023-03-09 | 日環科学株式会社 | 免疫賦活化製剤と当該免疫賦活製剤を含有する化粧品、食品、飼料添加物、医薬部外品 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004098533A2 (en) | 2003-05-05 | 2004-11-18 | Boyce Thompson Institute For Plant Research | Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| AU2005248375B2 (en) * | 2004-05-25 | 2010-12-16 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase varians |
| JP2009535306A (ja) | 2006-04-21 | 2009-10-01 | ダウ・アグロサイエンス・エル・エル・シー | 鳥インフルエンザに対するワクチンおよび使用方法 |
| EP2029167A4 (en) * | 2006-06-16 | 2010-06-16 | Dow Agrosciences Llc | NEW DNA SEQUENCES, VECTORS AND PROTEINS OF BIRD FLUID HEMOGGLUTININE |
-
2007
- 2007-06-08 EP EP07784373A patent/EP2029167A4/en not_active Withdrawn
- 2007-06-08 WO PCT/US2007/070755 patent/WO2007149715A2/en not_active Ceased
- 2007-06-08 AU AU2007261196A patent/AU2007261196A1/en not_active Abandoned
- 2007-06-08 KR KR1020087031047A patent/KR20090027216A/ko not_active Ceased
- 2007-06-08 CA CA002654178A patent/CA2654178A1/en not_active Abandoned
- 2007-06-08 US US12/299,404 patent/US8163876B2/en not_active Expired - Fee Related
- 2007-06-08 CN CNA2007800223807A patent/CN101472607A/zh active Pending
- 2007-06-08 JP JP2009515579A patent/JP2009540801A/ja active Pending
- 2007-06-08 BR BRPI0713671-4A2A patent/BRPI0713671A2/pt not_active IP Right Cessation
- 2007-06-15 AR ARP070102645A patent/AR061484A1/es not_active Application Discontinuation
-
2008
- 2008-10-16 ZA ZA200808845A patent/ZA200808845B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009540801A (ja) | 2009-11-26 |
| KR20090027216A (ko) | 2009-03-16 |
| WO2007149715A3 (en) | 2008-07-24 |
| ZA200808845B (en) | 2009-10-28 |
| EP2029167A4 (en) | 2010-06-16 |
| BRPI0713671A2 (pt) | 2013-12-03 |
| WO2007149715A2 (en) | 2007-12-27 |
| EP2029167A2 (en) | 2009-03-04 |
| AU2007261196A1 (en) | 2007-12-27 |
| US8163876B2 (en) | 2012-04-24 |
| CA2654178A1 (en) | 2007-12-27 |
| US20090106864A1 (en) | 2009-04-23 |
| CN101472607A (zh) | 2009-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR061484A1 (es) | Secuencias de adn vectores proteinas y usos de hemaglutinina de gripe aviar | |
| Lim et al. | Recent advances, approaches and challenges in the development of universal influenza vaccines | |
| ES2488941T3 (es) | Vectores y constructos de liberación de antígenos de virus de la gripe | |
| AR125392A2 (es) | Métodos y composiciones para la expresión génica en plantas | |
| AR108442A1 (es) | Proteínas de fusión gdf15 y usos de estas | |
| DK1968632T3 (da) | Forbedret influenzavaccine | |
| BRPI0815578B8 (pt) | Peptídeo de cdca1, seu uso e composição imunogênica compreendendo o mesmo para induzir imunidade, tratar e/ou prevenir o câncer, bem como método in vitro para induzir uma célula apresentadora de antígeno e uma célula t citotóxica (killer) | |
| CO6260151A2 (es) | Peptido de cdh3 y agente medicinal que comprende al mismo | |
| Isakova-Sivak et al. | Influenza vaccine: Progress in a vaccine that elicits a broad immune response | |
| IL288541B (en) | Vaccine against rsv | |
| JP2009540801A5 (enExample) | ||
| CL2012000447A1 (es) | Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica. | |
| AR079114A1 (es) | Proteinas de enlace de antigenos anti-orai1 y usos de las mismas | |
| JP2009535306A5 (enExample) | ||
| PE20090483A1 (es) | Vectores para la expresion multiple de genes | |
| CA3207612A1 (en) | Composite antigenic sequences and vaccines | |
| NZ627888A (en) | Materials and methods for respiratory disease control in canines | |
| NZ598605A (en) | Vaccine against african horse sickness virus | |
| AR094725A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
| BR112017014737A2 (pt) | formulação de peptídeos inibidores de mk2 | |
| PE20121171A1 (es) | Metodo, kit, plasmido y composicion para inducir una respuesta inmunitaria contra el virus del dengue basandose en vacunas de adn y virus quimericos | |
| MX381786B (es) | Gen insecticida variante axmi115 y métodos para utilizarlo. | |
| AR053372A1 (es) | Proteinas inmunologicas de lawsonia intracellularis | |
| CA2991213A1 (en) | Recombinant virus like particles using bovine immunodeficiency virus gag protein | |
| DE602005015368D1 (de) | Immunogenes polypeptid bestehend aus optimierten kryptischen peptiden aus tumorantigenen und seine verwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |